Azamian Bobak R. (CIK 1827672) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-22). Recent activity: Sell TARS (5,418 shares), Sell TARS (4,582 shares), Sell TARS (10,972 shares), Sell TARS (11,667 shares), Sell TARS (11,964 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Sell | 5,418 | $334,887 |
| 2026-06-22 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Sell | 4,582 | $280,602 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Sell | 10,972 | $761,676 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Sell | 11,667 | $801,640 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Sell | 11,964 | $801,588 |
| 2026-03-17 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Buy | 66,274 | $0 |
| 2025-12-30 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Sell | 5,443 | $448,558 |
| 2025-12-30 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Sell | 557 | $46,532 |
| 2025-12-08 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Sell | 51,885 | $0 |
| 2025-09-26 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Sell | 6,000 | $332,220 |
| 2025-08-13 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Sell | 6,000 | $300,000 |
| 2025-03-26 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Sell | 6,000 | $300,000 |
| 2025-03-20 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Sell | 7,131 | $330,094 |
| 2025-03-20 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Sell | 8,551 | $405,317 |
| 2025-03-20 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Sell | 8,534 | $427,639 |
| 2025-03-18 | Tarsus Pharmaceuticals, Inc. (TARS) | President/CEO and Board Chair | Buy | 51,395 | $0 |
Source: SEC Form 4 filings · as of 2026-06-22